D-0115-2021 Class III Terminated
FDA drug recall D-0115-2021 was initiated by InvaTech Pharma Solutions, LLC on Nov 11, 2020 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing. The recall status is terminated (terminated Jun 20, 2023).
Recall details
- Product Type
- Drugs
- Report Date
- Dec 9, 2020
- Initiation Date
- Nov 11, 2020
- Termination Date
- Jun 20, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex Pharmceuticals, Inc. New Castle, DE 19720. NDC 10135-0639-30
Reason for recall
Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing.
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot #: 051944A Exp. Date April - 2021; 1119124 Exp Date Oct - 2021; 062088 Exp Date June - 2022;
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0115-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026